New daily pill aims to rival semaglutide for diabetes and weight loss
NCT ID NCT07662213
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 3 study tests a new oral drug, elecoglipron, against the approved pill semaglutide in adults with type 2 diabetes who also have increased heart risk. The goal is to see which works better for lowering blood sugar and body weight over about a year. Participants take one of the two pills daily, and researchers track changes in HbA1c and weight.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Elecoglipron (oral drug)
What this could lead to
If successful, elecoglipron could offer a new once-daily pill option for managing blood sugar and weight in people with type 2 diabetes.
What could go wrong
This is a phase 3 trial, so results are not yet known. Elecoglipron may not prove better or safer than existing treatments like semaglutide.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
Birmingham, Alabama, 35205, United States
-
Research Site
Mesa, Arizona, 85213, United States
-
Research Site
Phoenix, Arizona, 85016, United States
-
Research Site
Tempe, Arizona, 85281, United States
-
Research Site
Encinitas, California, 92024, United States
-
Research Site
Garden Grove, California, 92844, United States
-
Research Site
Lincoln, California, 95648, United States
-
Research Site
Loma Linda, California, 92350, United States
-
Research Site
Pomona, California, 91768, United States
-
Research Site
Crystal River, Florida, 34429, United States
-
Research Site
Hollywood, Florida, 33021, United States
-
Research Site
Jacksonville, Florida, 32209, United States
-
Research Site
Leesburg, Florida, 34748, United States
-
Research Site
Idaho Falls, Idaho, 83404, United States
-
Research Site
Melrose Park, Illinois, 60160, United States
-
Research Site
Ames, Iowa, 50010, United States
-
Research Site
Wichita, Kansas, 67226, United States
-
Research Site
Bowling Green, Kentucky, 42101, United States
-
Research Site
Rockville, Maryland, 20852, United States
-
Research Site
Southfield, Michigan, 48076, United States
-
Research Site
Jefferson City, Missouri, 65109, United States
-
Research Site
Kansas City, Missouri, 64114, United States
-
Research Site
Omaha, Nebraska, 68114, United States
-
Research Site
Henderson, Nevada, 89052, United States
-
Research Site
Las Vegas, Nevada, 89128, United States
-
Research Site
Albuquerque, New Mexico, 87112, United States
-
Research Site
Durham, North Carolina, 27701, United States
-
Research Site
Morehead City, North Carolina, 28557, United States
-
Research Site
Statesville, North Carolina, 28625, United States
-
Research Site
Wilmington, North Carolina, 28403, United States
-
Research Site
Columbus, Ohio, 43215, United States
-
Research Site
Yukon, Oklahoma, 73099, United States
-
Research Site
Dallas, Texas, 75390, United States
-
Research Site
Sugar Land, Texas, 77478, United States
-
Research Site
Bountiful, Utah, 84010, United States
-
Research Site
Salt Lake City, Utah, 84124, United States
-
Research Site
Leesburg, Virginia, 20176, United States
-
Research Site
Norfolk, Virginia, 23502, United States
-
Research Site
Seattle, Washington, 98104, United States
-
Research Site
Seattle, Washington, 98105, United States
-
Research Site
Morgantown, West Virginia, 26505, United States
-
Research Site
Buenos Aires, C1425AGC, Argentina
-
Research Site
CABA, C1120AAC, Argentina
-
Research Site
Caba, C1128AAF, Argentina
-
Research Site
Ciudad de Buenos Aires, C1094AAD, Argentina
-
Research Site
Rosario, S2000CVD, Argentina
-
Research Site
San Nicolás, B2900DMH, Argentina
-
Research Site
San Vicente, 5006, Argentina
-
Research Site
East Toowoomba, 4350, Australia
-
Research Site
Melbourne, 3004, Australia
-
Research Site
Parkville, 3050, Australia
-
Research Site
St Leonards, 2065, Australia
-
Research Site
Brasília, 71625-009, Brazil
-
Research Site
Campinas, 13060-904, Brazil
-
Research Site
Curitiba, 80030-480, Brazil
-
Research Site
Natal, 59020-035, Brazil
-
Research Site
Porto Alegre, 90630-165, Brazil
-
Research Site
São José dos Campos, 12243-280, Brazil
-
Research Site
São Paulo, 04012-180, Brazil
-
Research Site
Plovdiv, 4001, Bulgaria
-
Research Site
Sofia, 1407, Bulgaria
-
Research Site
Sofia, 1618, Bulgaria
-
Research Site
Sofia, 1700, Bulgaria
-
Research Site
Yambol, 8600, Bulgaria
-
Research Site
Vancouver, British Columbia, V5Y 3W2, Canada
-
Research Site
Sarnia, Ontario, N7T 4X3, Canada
-
Research Site
Scarborough Village, Ontario, M1R 0B1, Canada
-
Research Site
Stouffville, Ontario, L4A1H2, Canada
-
Research Site
Toronto, Ontario, M4G3E8, Canada
-
Research Site
Toronto, Ontario, M9V 4B4, Canada
-
Research Site
Montreal, Quebec, H4N 2W2, Canada
-
Research Site
Saint-Charles-Borromée, Quebec, J6E 2B4, Canada
-
Research Site
Changsha, 410013, China
-
Research Site
Changsha, 410015, China
-
Research Site
Hefei, 230601, China
-
Research Site
Huai'an, 223005, China
-
Research Site
Liangyugang, 222002, China
-
Research Site
Nanjing, 2100008, China
-
Research Site
Nanyang, 473009, China
-
Research Site
Pingxiang, 337055, China
-
Research Site
Bad Oeynhausen, 32545, Germany
-
Research Site
Berlin, 13597, Germany
-
Research Site
Chemnitz, 09116, Germany
-
Research Site
Damme, 49401, Germany
-
Research Site
Duisburg, 47051, Germany
-
Research Site
Elsterwerda, 04910, Germany
-
Research Site
Erlangen, 91054, Germany
-
Research Site
Essen, 45359, Germany
-
Research Site
Falkensee, 14612, Germany
-
Research Site
Gladbeck, 45968, Germany
-
Research Site
Hamburg, 21109, Germany
-
Research Site
Hamburg, 22607, Germany
-
Research Site
Leipzig, 04249, Germany
-
Research Site
Mannheim, 68167, Germany
-
Research Site
Münster, 48145, Germany
-
Research Site
Oldenburg, 23758, Germany
-
Research Site
Pirna, 01796, Germany
-
Research Site
Sankt Ingbert, 66386, Germany
-
Research Site
Wangen, 88239, Germany
-
Research Site
Budapest, 1036, Hungary
-
Research Site
Budapest, 1089, Hungary
-
Research Site
Budapest, 1132, Hungary
-
Research Site
Debrecen, 4032, Hungary
-
Research Site
Salgótarján, 3100, Hungary
-
Research Site
Szeged, 6725, Hungary
-
Research Site
Szolnok, 5000, Hungary
-
Research Site
Zalaegerszeg, 8900, Hungary
-
Research Site
Bari, 70124, Italy
-
Research Site
Bologna, 40138, Italy
-
Research Site
Chieti, 66100, Italy
-
Research Site
Milan, 20132, Italy
-
Research Site
Milan, 20138, Italy
-
Research Site
Modena, 41100, Italy
-
Research Site
Naples, 80138, Italy
-
Research Site
Roma, 00161, Italy
-
Research Site
Roma, 00168, Italy
-
Research Site
Asahikawa-shi, 070-8530, Japan
-
Research Site
Chūōku, 103-0002, Japan
-
Research Site
Kamakura-shi, 247-0056, Japan
-
Research Site
Koga-shi, 306-0232, Japan
-
Research Site
Mito, 310-0826, Japan
-
Research Site
Miyazaki, 880-0034, Japan
-
Research Site
Nagoya, 468-0009, Japan
-
Research Site
Naka, 311-0113, Japan
-
Research Site
Bialystok, 15-897, Poland
-
Research Site
Krakow, 31-261, Poland
-
Research Site
Lodz, 90-338, Poland
-
Research Site
Lublin, 20-718, Poland
-
Research Site
Poznan, 60-354, Poland
-
Research Site
Radom, 26-600, Poland
-
Research Site
Warsaw, 00-124, Poland
-
Research Site
Warsaw, 02-507, Poland
-
Research Site
Daegu, 41404, South Korea
-
Research Site
Daejeon, 35015, South Korea
-
Research Site
Guri-si, 11923, South Korea
-
Research Site
Incheon, 21565, South Korea
-
Research Site
Seoul, 05278, South Korea
-
Research Site
Seoul, 06351, South Korea
-
Research Site
Changhua, 50006, Taiwan
-
Research Site
Kaohsiung City, 81362, Taiwan
-
Research Site
New Taipei City, 220, Taiwan
-
Research Site
Taichung, 40201, Taiwan
-
Research Site
Taichung, 40705, Taiwan
-
Research Site
Taichung, 433004, Taiwan
-
Research Site
Tainan, 704, Taiwan
-
Research Site
Taipei, 10002, Taiwan
-
Research Site
Taoyuan, 333, Taiwan
-
Research Site
Yung Kang City, 71044, Taiwan
-
Research Site
Aberdeen, AB25 2ZN, United Kingdom
-
Research Site
Banbury, OX16 9AD, United Kingdom
-
Research Site
Bristol, BS34 6BQ, United Kingdom
-
Research Site
Edinburgh, EH4 2XU, United Kingdom
-
Research Site
Hounslow, TW3 3LN, United Kingdom
-
Research Site
Penzance, TR18 3DX, United Kingdom
-
Research Site
Poole, BH16 5PW, United Kingdom
-
Research Site
Soham, CB7 5JD, United Kingdom
-
Research Site
Wansford, PE8 6PL, United Kingdom
-
Research Site
Yate, BS37 4AX, United Kingdom